KALARIS THERAPEUTICS, INC. Management Fee Expense
KALARIS THERAPEUTICS, INC. (KLRS) reported Management Fee Expense of $20.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ManagementFeeExpense · last filed 2026-08-11
- KALARIS THERAPEUTICS, INC. management fee expense for the quarter ending 2026-06-30 was $20.00K.
- KALARIS THERAPEUTICS, INC. management fee expense for the quarter ending 2026-03-31 was $20.00K, a 100.00% increase year-over-year.
- KALARIS THERAPEUTICS, INC. management fee expense for the quarter ending 2025-03-31 was $10.00K, a 90.00% decline year-over-year.
- KALARIS THERAPEUTICS, INC. management fee expense for the quarter ending 2024-12-31 was $0.00, a 100.00% decline year-over-year.
- KALARIS THERAPEUTICS, INC. management fee expense for fiscal 2025 was $100.00K, a 0.00% change from fiscal 2024.
- KALARIS THERAPEUTICS, INC. management fee expense for fiscal 2024 was $100.00K, a 75.00% decline from fiscal 2023.
- KALARIS THERAPEUTICS, INC. management fee expense for fiscal 2023 was $400.00K, a 20.00% decline from fiscal 2022.
- KALARIS THERAPEUTICS, INC. management fee expense for fiscal 2022 was $500.00K, a 0.00% change from fiscal 2021.
| Period end | Management Fee Expense 3 month | Management Fee Expense 6 month | Management Fee Expense 9 month | Management Fee Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $20.00K 10-Q · filed 2026-08-11 | $30.00K 10-Q · filed 2026-08-11 | ||
| 2026-03-31 | $20.00K 10-Q · filed 2026-05-12 | |||
| 2025-12-31 | $100.00K 10-K · filed 2026-03-17 | |||
| 2025-03-31 | $10.00K 10-Q · filed 2026-05-12 | $10.00K derived: sum of 2 quarters · filed 2026-05-12 | $10.00K derived: sum of 3 quarters · filed 2026-05-12 | $110.00K derived: sum of 4 quarters · filed 2026-05-12 |
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-17 | $0.00 derived: sum of 2 quarters · filed 2026-03-17 | $100.00K derived: sum of 3 quarters · filed 2026-03-17 | $100.00K 10-K · filed 2026-03-17 |
| 2024-09-30 | $0.00 10-Q · filed 2024-11-12 | $100.00K derived: sum of 2 quarters · filed 2024-11-12 | $100.00K 10-Q · filed 2024-11-12 | $300.00K derived: sum of 4 quarters · filed 2025-03-07 |
| 2024-06-30 | $100.00K 10-Q · filed 2024-08-09 | $100.00K 10-Q · filed 2024-08-09 | $300.00K derived: sum of 3 quarters · filed 2025-03-07 | $400.00K derived: sum of 4 quarters · filed 2025-03-07 |
| 2024-03-31 | $100.00K 10-Q · filed 2024-05-13 | $200.00K derived: sum of 2 quarters · filed 2025-03-07 | $300.00K derived: sum of 3 quarters · filed 2025-03-07 | $400.00K derived: sum of 4 quarters · filed 2025-03-07 |
| 2023-12-31 | $100.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-07 | $200.00K derived: sum of 2 quarters · filed 2025-03-07 | $300.00K derived: sum of 3 quarters · filed 2025-03-07 | $400.00K 10-K · filed 2025-03-07 |
| 2023-09-30 | $100.00K 10-Q · filed 2024-11-12 | $200.00K derived: sum of 2 quarters · filed 2024-11-12 | $300.00K 10-Q · filed 2024-11-12 | $400.00K derived: sum of 4 quarters · filed 2024-11-12 |
| 2023-06-30 | $100.00K 10-Q · filed 2024-08-09 | $200.00K 10-Q · filed 2024-08-09 | $300.00K derived: sum of 3 quarters · filed 2024-08-09 | $400.00K derived: sum of 4 quarters · filed 2024-08-09 |
| 2023-03-31 | $100.00K 10-Q · filed 2024-05-13 | $200.00K derived: sum of 2 quarters · filed 2024-05-13 | $300.00K derived: sum of 3 quarters · filed 2024-05-13 | $400.00K derived: sum of 4 quarters · filed 2024-05-13 |
| 2022-12-31 | $100.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-15 | $200.00K derived: sum of 2 quarters · filed 2024-03-15 | $300.00K derived: sum of 3 quarters · filed 2024-03-15 | $500.00K 10-K · filed 2024-03-15 |
| 2022-09-30 | $100.00K 10-Q · filed 2023-11-02 | $200.00K derived: sum of 2 quarters · filed 2023-11-02 | $400.00K 10-Q · filed 2023-11-02 | $600.00K derived: sum of 4 quarters · filed 2023-11-02 |
| 2022-06-30 | $100.00K 10-Q · filed 2023-08-03 | $300.00K 10-Q · filed 2023-08-03 | $500.00K derived: sum of 3 quarters · filed 2023-08-03 | $600.00K derived: sum of 4 quarters · filed 2023-08-03 |
| 2022-03-31 | $200.00K 10-Q · filed 2023-05-04 | $400.00K derived: sum of 2 quarters · filed 2023-05-04 | $500.00K derived: sum of 3 quarters · filed 2023-05-04 | $600.00K derived: sum of 4 quarters · filed 2023-05-04 |
| 2021-12-31 | $200.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-15 | $300.00K derived: sum of 2 quarters · filed 2023-02-15 | $400.00K derived: sum of 3 quarters · filed 2023-02-15 | $500.00K 10-K · filed 2023-02-15 |
| 2021-09-30 | $100.00K 10-Q · filed 2022-11-03 | $200.00K derived: sum of 2 quarters · filed 2022-11-03 | $300.00K 10-Q · filed 2022-11-03 | $500.00K derived: sum of 4 quarters · filed 2022-11-03 |
| 2021-06-30 | $100.00K 10-Q · filed 2022-08-04 | $300.00K 10-Q · filed 2022-08-04 | $400.00K derived: sum of 3 quarters · filed 2022-08-04 | $500.00K derived: sum of 4 quarters · filed 2022-08-04 |
| 2021-03-31 | $200.00K 10-Q · filed 2022-05-05 | $300.00K derived: sum of 2 quarters · filed 2022-05-05 | $400.00K derived: sum of 3 quarters · filed 2022-05-05 | $500.00K derived: sum of 4 quarters · filed 2022-05-05 |
| 2020-12-31 | $100.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-10 | $200.00K derived: sum of 2 quarters · filed 2022-02-10 | $300.00K derived: sum of 3 quarters · filed 2022-02-10 | $600.00K 10-K · filed 2022-02-10 |
| 2020-09-30 | $100.00K 10-Q · filed 2021-11-05 | $200.00K derived: sum of 2 quarters · filed 2021-11-05 | $500.00K 10-Q · filed 2021-11-05 | $600.00K derived: sum of 4 quarters · filed 2021-11-05 |
| 2020-06-30 | $100.00K 10-Q · filed 2021-08-06 | $400.00K 10-Q · filed 2021-08-06 | $500.00K derived: sum of 3 quarters · filed 2021-08-06 | $600.00K derived: sum of 4 quarters · filed 2021-08-06 |
| 2020-03-31 | $300.00K 10-Q · filed 2021-05-06 | $400.00K derived: sum of 2 quarters · filed 2021-05-06 | $500.00K derived: sum of 3 quarters · filed 2021-05-06 | $600.00K derived: sum of 4 quarters · filed 2021-05-06 |
| 2019-12-31 | $100.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-12 | $200.00K derived: sum of 2 quarters · filed 2021-02-12 | $300.00K derived: sum of 3 quarters · filed 2021-02-12 | $400.00K 10-K · filed 2021-02-12 |
| 2019-09-30 | $100.00K 10-Q · filed 2020-11-10 | $200.00K derived: sum of 2 quarters · filed 2020-11-10 | $300.00K 10-Q · filed 2020-11-10 | |
| 2019-06-30 | $100.00K 10-Q · filed 2020-09-02 | $100.00K 10-Q · filed 2020-09-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |
| Pelthos Therapeutics Inc. (PTHS) | United States | $0.086B | -1.20 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| COGNITION THERAPEUTICS INC (CGTX) | United States | $0.090B | -6.52 |